PMI U.S. opens $1.2 billion Aurora campus
The Colorado facility will produce ZYN nicotine pouches and create 500 jobs, strengthening U.S. manufacturing and export capabilities.
See the latest news and media coverage for PMI. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
In short: PMI accelerated its smoke-free transition, investing $1.2 billion in U.S. ZYN production while reporting that alternatives reached 42% of revenue.
The Colorado facility will produce ZYN nicotine pouches and create 500 jobs, strengthening U.S. manufacturing and export capabilities.
Emmanuel Babeau discussed the company's transformation powered by science and innovation.
Adjusted diluted EPS grew 15.2% to $2.20, driven by smoke-free growth and pricing.
The webcast on July 22 will discuss financial performance and include Q&A.
Philip Morris International Inc. (NYSE:PM) cut its 2026 adjusted earnings forecast for the third time this year on July 22. Nevertheless, the shares rose about...
The additional investment will help meet rising demand for Zyn nicotine pouches.
FDA authorizations for IQOS and ZYN give it a regulatory edge over Altria and British American Tobacco.
Philip Morris stock is downgraded to "Hold" as valuations are stretched and forecasts limit upside. Here's what investors need to know about PM.
Track PMI and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to PMI and other trending companies.